Business Context and Reporting Period
This Form 8-K filing by American Healthcare REIT, Inc. (AHR) reports a significant capital event dated August 10, 2026, with the transaction closing on August 12, 2026. The company, a Maryland-domiciled REIT, executed a public offering of common stock to fund strategic growth initiatives.
Key Financial Metrics and Transaction Details
- Offering Size: 13,250,000 shares of Common Stock ($0.01 par value).
- Underwriters: Morgan Stanley & Co. LLC, Citigroup Global Markets Inc., and KeyBanc Capital Markets Inc.
- Transaction Structure: The offering utilized a forward sale agreement structure. The underwriters acted as forward sellers, borrowing and selling shares to hedge obligations, with the company intending to deliver shares upon physical settlement.
- Settlement Terms: Settlement is expected on dates specified by the company no later than August 10, 2028. Proceeds will be calculated as the public offering price less underwriting discounts and commissions.
- Over-Allotment Option: Underwriters were granted a 30-day option to purchase up to 1,987,500 additional shares.
- Use of Proceeds: Net proceeds are designated for the pending acquisition of a portfolio of senior housing properties, potential future investments, and general corporate purposes.
Material Changes
The filing discloses a material change in the company's capital structure through the issuance of new equity. The transaction represents a shift from a forward sale agreement commitment to a closed public offering, increasing the number of outstanding shares pending final settlement. No prior comparable period financial metrics (revenue, profit, cash flow) are provided in this specific filing.
Guidance, Outlook, and Risks
Management Commentary: The company intends to contribute net proceeds to its Operating Partnership in exchange for limited partnership units. The primary strategic focus is the acquisition of senior housing properties.
Risks and Contingencies:
- Settlement Timing: The final delivery of shares and receipt of cash proceeds are contingent on settlement dates occurring no later than August 10, 2028.
- Settlement Method: The company retains the right to elect cash or net share settlement subject to certain conditions.
- Forward Sale Adjustments: The forward sale price is subject to adjustments as provided in the Forward Sale Agreements.
Investor Verification Checklist
- Verify the final public offering price per share and total net proceeds once the settlement occurs.
- Confirm the specific details of the "pending acquisition of a portfolio of senior housing properties" referenced in the use of proceeds.
- Monitor whether the underwriters exercise the option to purchase the additional 1,987,500 shares.
- Review the definitive Forward Sale Agreements (Exhibits 1.2, 1.3, 1.4) for specific adjustment formulas and settlement conditions.
- Check subsequent filings for the actual settlement date and the final number of shares issued.